Analyst firms · BofA Securities · OGN

BofA Securities OGN price target and rating history

Organon & Co. (OGN) · Health Care

BofA Securities rates Organon & Co. (OGN) Underperform with a $25 price target, as of its latest action on Oct 14, 2022. It has published 3 rating actions on OGN since September 2021, including 0 upgrades and 2 downgrades.

Current rating
Underperform
Price target
$25
Median target, all firms
Too few
Actions on OGN
3

BofA Securities price target on OGN

$43$34$2520222023202420252026
BofA Securities price target on OGN, each point a stated target, September 2021 to October 2022.

Every BofA Securities rating on OGN

How other firms rate OGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerNeutral$14Apr 28, 2026
BarclaysUnderweight$7.50Dec 9, 2025

Questions about BofA Securities and OGN

What is BofA Securities's price target for OGN?
BofA Securities's latest stated price target for Organon & Co. (OGN) is $25, from its action on Oct 14, 2022.
What is BofA Securities's rating on OGN?
BofA Securities rates OGN Underperform, a bearish rating, as of Oct 14, 2022.
When did BofA Securities last change its view on OGN?
On Oct 14, 2022, BofA Securities downgrades to Underperform from Neutral, price target $27 to $25.

More OGN rating histories

All BofA Securities ratingsOGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.